Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling - Wikidata - awgldk - TriplyDB

Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling

Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling

http://www.wikidata.org/entity/Q28308310

about

What Kind of Signaling Maintains Pluripotency and Viability in Human-Induced Pluripotent Stem Cells Cultured on Laminin-511 with Serum-Free Medium?P2Y12 receptor expression is a critical determinant of functional responsiveness to ATX's MORFO domain Protein-tyrosine phosphatase alpha acts as an upstream regulator of Fyn signaling to promote oligodendrocyte differentiation and myelination NMDA receptor couples Rac1-GEF Tiam1 to direct oligodendrocyte precursor cell migration Activation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells.Myosin II is a negative regulator of oligodendrocyte morphological differentiation.Physical forces in myelination and repair: a question of balance?Mechanical Strain Promotes Oligodendrocyte Differentiation by Global Changes of Gene Expression Inhibition of TROY promotes OPC differentiation and increases therapeutic efficacy of OPC graft for spinal cord injury Chemical biology in stem cell research.LINGO-1, a transmembrane signaling protein, inhibits oligodendrocyte differentiation and myelination through intercellular self-interactions.A regenerative approach to the treatment of multiple sclerosis.Activation of endogenous neural stem cells for multiple sclerosis therapy.Extracellular acidic pH inhibits oligodendrocyte precursor viability, migration, and differentiation Cellular response to micropatterned growth promoting and inhibitory substrates Quercetin promotes proliferation and differentiation of oligodendrocyte precursor cells after oxygen/glucose deprivation-induced injury.Dysfunction of platelet-derived growth factor receptor α (PDGFRα) represses the production of oligodendrocytes from arylsulfatase A-deficient multipotential neural precursor cells Cell therapy for multiple sclerosis.Glia Disease and Repair-Remyelination A new in vitro mouse oligodendrocyte precursor cell migration assay reveals a role for integrin-linked kinase in cell motility Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination The Orphan G Protein-coupled Receptor GPR17 Negatively Regulates Oligodendrocyte Differentiation via Gαi/o and Its Downstream Effector Molecules.Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.Fyn Mediates High Glucose-Induced Actin Cytoskeleton Reorganization of Podocytes via Promoting ROCK Activation In Vitro.Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status Characterization of glucose-related metabolic pathways in differentiated rat oligodendrocyte lineage cells Clobetasol promotes remyelination in a mouse model of neuromyelitis optica Rejuvenation of regeneration in the aging central nervous system.SCISSOR-Spinal Cord Injury Study on Small molecule-derived Rho inhibition: a clinical study protocol.Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system.Myelin-based inhibitors of oligodendrocyte myelination: clues from axonal growth and regeneration.Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination.Factors that retard remyelination in multiple sclerosis with a focus on TIP30: a novel therapeutic target.Fyn kinase inhibition as a novel therapy for Alzheimer's disease.Enhancing remyelination in disease--can we wrap it up?The complex world of oligodendroglial differentiation inhibitors.Integrin signaling in oligodendrocytes and its importance in CNS myelination.Myelin regeneration in multiple sclerosis: targeting endogenous stem cells Systematic approaches to central nervous system myelin.Improving myelin/oligodendrocyte-related dysfunction: a new mechanism of antipsychotics in the treatment of schizophrenia?

P2860

Q26751606-0B4BDE3E-5B7E-4B04-BAE3-8AE3042C0BD8 Q28568115-DC4DD396-A96F-4D66-A670-6827F8031CA6 Q28577221-E8846705-F022-462E-BC94-28F79D81ECAA Q28580426-E9745115-E6C3-445A-9D72-ECD5B30045AE Q29568315-2809A633-3126-47EC-8AF8-D6D2ED9D2AC8 Q30515379-94779BEF-33CA-4F67-9233-A7D6F03C9061 Q33508686-0E7D7E6F-4DE2-497C-B1FD-AA7BC550DE37 Q33581205-A8A4B4FB-965C-44EE-B55C-9D85A53642A2 Q34081947-583BD82E-7903-458E-9110-866AF6C9D98B Q34174339-F211120D-8863-4C0D-8C38-B7F83A7A07ED Q34269251-CA5D1073-D065-42D6-A77C-2C53A9E1C046 Q34376469-E2233458-AA97-4E9C-9357-D678882AFB7C Q34986269-BE9E5F7F-C01E-40D1-921A-643193E3CEB0 Q35010204-C6334540-169B-4EF3-9AC6-3D5140807FE6 Q35015920-E1042B53-E3AD-4897-BDED-EEA527A49E16 Q35092454-CBB0BE96-6CA5-4979-BAED-3011A7D61AFD Q35172658-53141F10-9133-4FD0-A5E1-B6D21AFCE0D2 Q35648117-F8E91E95-2C60-473C-A989-0532139DFDA2 Q35795587-7780731F-6458-416F-8931-9C2E2E7AD06B Q35910607-86B3DC47-7D3F-4FF2-946F-462E84BC1582 Q36344854-D69A21EA-BD04-4092-B7F8-21F29696118B Q36442376-160FA422-9540-464F-B33B-45DAF03F2E70 Q36465147-7BDAFA78-5269-418F-9E34-FE2594ABE6FB Q36531604-122A922D-0947-43A1-8006-D7C7887A71A8 Q36722852-86CA35D8-2308-440D-82A9-273F25D8E986 Q36799976-24322F4B-5245-4EA9-AB71-FC76715C6A29 Q36836541-86E833A1-969F-4A71-B462-40DF75601A0C Q37023170-A863D1E3-00AD-4149-B302-D72FC41D4FF6 Q37133751-06DA4194-9320-46D7-99F6-3828A74E50A1 Q37198963-BE483DA0-898D-4E77-A27F-E77BEAFB98A7 Q37537088-5AA28AA2-F77A-4537-ABE4-FD18E43D651C Q37557188-AD143F5D-BF7E-4D2E-88BE-CB7628FDD961 Q37617353-2AF58FB2-2732-40B7-87EC-76A1A170441C Q37689640-79BA81FA-4A19-4815-ACB4-6936FE12F49F Q37867334-3D875D8E-3613-4444-8C64-C5C257034DAE Q37869047-208DBC8E-964C-4F95-870C-080474A6C502 Q37884392-07FF24F1-6501-4995-9D98-A52B64283F0C Q37929620-B1D45E55-DEAD-4B33-A9A1-D214CF7D34AD Q37996290-0CBED5DC-BB41-42D9-A1DB-2C67C35A4B51 Q38060893-B5D66C9D-5F8F-460C-94CA-E1B7F7AE5C88

P2860

Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling

http://www.wikidata.org/entity/Q28308310

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Myelin-mediated inhibition of ...... nd protein kinase C signalling

@ast

Myelin-mediated inhibition of ...... nd protein kinase C signalling

@en

Myelin-mediated inhibition of ...... nd protein kinase C signalling

@nl

type

label

Myelin-mediated inhibition of ...... nd protein kinase C signalling

@ast

Myelin-mediated inhibition of ...... nd protein kinase C signalling

@en

Myelin-mediated inhibition of ...... nd protein kinase C signalling

@nl

prefLabel

Myelin-mediated inhibition of ...... nd protein kinase C signalling

@ast

Myelin-mediated inhibition of ...... nd protein kinase C signalling

@en

Myelin-mediated inhibition of ...... nd protein kinase C signalling

@nl

P1433

Q28308310-F2B4A615-B87E-4DC8-9821-C8516D94CDBC

P1476

Q28308310-039AE78F-C07C-4CF3-B763-A254B97CABA0

P2093

Q28308310-01217ADD-1AE5-452C-A942-3288A62D68EF

Q28308310-1BFB6070-A3A9-4005-9ACC-079B6846AA2B

Q28308310-1F24D6AC-BAF3-42B9-821A-61A5CA1ECC8A

Q28308310-21D508AD-F8D5-4CC3-ACDD-617D99737E43

Q28308310-550DE027-4C9D-42FD-8A0B-7BC7E7DE9DB3

P2860

Q28308310-03B47B83-06CB-4E60-B165-ED66607B778E

Q28308310-06A1DBF6-211B-4F81-A42F-1614F6D36E7B

Q28308310-06D5B366-2677-455F-A229-6B196BD434FE

Q28308310-10AB2AFB-7EF8-4EE0-B932-3C454CB9CA4B

Q28308310-10FEF1DF-215E-446B-AA61-67104A6CF127

Q28308310-11060CC9-4953-4F99-884C-F3C54FDB1FD3

Q28308310-129E0EC9-2978-456B-A580-A25980C9C53D

Q28308310-138D48E2-4BEA-48FD-92E5-B83916E3AE2F

Q28308310-19BAFE57-2012-45E2-A2B2-076359C31B6D

Q28308310-19EEC939-80EF-47D7-AB45-2D8324E47B34

P304

Q28308310-C98928E4-28E0-4195-88F5-9EDC30B0FC34

P31

Q28308310-9E716DDF-5680-4D34-9E71-0453A5335D1C

P3181

Q28308310-5028C4E9-05DD-46D9-8050-6595A0C2739F

P356

Q28308310-5FAE3834-0020-4BF4-A42A-B59878484C72

P407

Q28308310-23A2C1DD-4547-49B2-8E89-CE06BBD25836

P433

Q28308310-C29ED195-2B59-41C3-9CE3-6071B73E9A82

P478

Q28308310-CAD29211-6BD6-4E1F-9D66-ABD693D0AE9B

P50

Q28308310-40FFCC05-3BB8-4AC8-A5B3-E4C82CB6E97A

Q28308310-5FF4824E-CA8B-43E9-AA54-0EB8BD9BDD2C

Q28308310-8A5A41FB-8119-437A-9939-8CA46A2C0CAF

Q28308310-A35B3F20-0C3F-42DD-8C62-1E1F36A93B1F

Q28308310-B879ADAF-965F-4C2E-86BE-18549E01976A

P577

Q28308310-05CF740C-1E65-4F5C-B798-65D711D3A6E4

P5875

Q28308310-4CF5A246-7244-4420-9434-5F23AB6E30F8

P698

Q28308310-D2C342F1-DAB3-4310-8A5E-3A2F245DF2F8

P921

Q28308310-CBAB2489-22BD-439D-B8CB-D765507A3572

Q28308310-F6E044C2-462D-4B4C-A50A-F57F40F9603C

P932

Q28308310-7973D6B8-F7AC-429C-9CCB-128A199B504A

P3181

P356

P1433

P1476

Myelin-mediated inhibition of ...... nd protein kinase C signalling

@en

P2093

Alexandra S Baer

http://www.w3.org/2001/XMLSchema#string

Charles Ffrench-Constant

http://www.w3.org/2001/XMLSchema#string

Dieter Mitteregger

http://www.w3.org/2001/XMLSchema#string

Raluca Vig

http://www.w3.org/2001/XMLSchema#string

Sung Ung Kang

http://www.w3.org/2001/XMLSchema#string

P2860

Rocks: multifunctional kinases in cell behaviour

Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study

Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells

Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation

Blue native PAGE

Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII

Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development

Proteolipid protein is required for transport of sirtuin 2 into CNS myelin

Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination

LINGO-1 negatively regulates myelination by oligodendrocytes

P304

465-481

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2084062

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/BRAIN/AWN334

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P50

Friedrich Altmann

Robin J.M. Franklin

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23999103

http://www.w3.org/2001/XMLSchema#string

P698

19208690

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte

P932

2640211

http://www.w3.org/2001/XMLSchema#string